These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1404239)

  • 1. N-(1-oxododecyl)-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol: a potent competitive inhibitor of 2,3-oxidosqualene cyclase.
    Wannamaker MW; Waid PP; Van Sickle WA; McCarthy JR; Wilson PK; Schatzman GL; Moore WR
    J Med Chem; 1992 Sep; 35(19):3581-3. PubMed ID: 1404239
    [No Abstract]   [Full Text] [Related]  

  • 2. Potent inhibition of cholesterol biosynthesis in 3T3 fibroblasts by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol, a new 2,3-oxidosqualene cyclase inhibitor.
    Gerst N; Duriatti A; Schuber F; Taton M; Benveniste P; Rahier A
    Biochem Pharmacol; 1988 May; 37(10):1955-64. PubMed ID: 3377803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-[(1,5,9)-trimethyl-decyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol a novel potent inhibitor of 2,3-oxidosqualene cycloartenol and lanosterol cyclases.
    Taton M; Benveniste P; Rahier A
    Biochem Biophys Res Commun; 1986 Jul; 138(2):764-70. PubMed ID: 3741433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternative mechanism for the inhibition of cholesterol biosynthesis in HepG2 cells by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol (MDL 28,815).
    Van Sickle WA; Wilson PK; Wannamaker MW; Cooper JR; Flanagan MA; McCarthy JR; Bey P; Jackson RL
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1243-9. PubMed ID: 8263786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and stereoelectronic requirements for the inhibition of mammalian 2,3-oxidosqualene cyclase by substituted isoquinoline derivatives.
    Barth MM; Binet JL; Thomas DM; de Fornel DC; Samreth S; Schuber FJ; Renaut PP
    J Med Chem; 1996 Jun; 39(12):2302-12. PubMed ID: 8691425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro inhibition of animal and higher plants 2,3-oxidosqualene-sterol cyclases by 2-aza-2,3-dihydrosqualene and derivatives, and by other ammonium-containing molecules.
    Duriatti A; Bouvier-Nave P; Benveniste P; Schuber F; Delprino L; Balliano G; Cattel L
    Biochem Pharmacol; 1985 Aug; 34(15):2765-77. PubMed ID: 4015713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a 2,3-oxidosqualene-lanosterol cyclase inhibitor 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line HepG2.
    Dollis D; Schuber F
    Biochem Pharmacol; 1994 Jul; 48(1):49-57. PubMed ID: 8043030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cholesterol biosynthesis in Chinese hamster ovary cells by 4,4,10 beta-trimethyl-trans-decal-3 beta-ol. A specific 2,3-oxidosqualene cyclase inhibitor.
    Chang TY; Schiavoni ES; McCrae KR; Nelson JA; Spencer TA
    J Biol Chem; 1979 Nov; 254(22):11258-63. PubMed ID: 500643
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitory activity of 8-azadecalin derivatives towards 2,3-oxidosqualene:lanosterol cyclases from baker's yeast and pig's liver.
    Hoshino T; Kobayashi N; Ishibashi E; Hashimoto S
    Biosci Biotechnol Biochem; 1995 Apr; 59(4):602-9. PubMed ID: 7772824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure activity relationships of new inhibitors of mammalian 2,3-oxidosqualene cyclase designed from isoquinoline derivatives.
    Binet J; Thomas D; Benmbarek A; de FD; Renaut P
    Chem Pharm Bull (Tokyo); 2002 Mar; 50(3):316-29. PubMed ID: 11911193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and in vitro evaluation of pyridinium ion based cyclase inhibitors and antifungal agents.
    Rose IC; Sharpe BA; Lee RC; Griffin JH; Capobianco JO; Zakula D; Goldman RC
    Bioorg Med Chem; 1996 Jan; 4(1):97-103. PubMed ID: 8689245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific syntheses of trans-vinyldioxidosqualene and 3-hydroxysulfide derivatives, as potent and time-dependent 2,3-oxidosqualene cyclase inhibitors.
    Viola F; Balliano G; Milla P; Cattel L; Rocco F; Ceruti M
    Bioorg Med Chem; 2000 Jan; 8(1):223-32. PubMed ID: 10968281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of new (2E,6E)-10-(dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol ethers as inhibitors of human and Trypanosoma cruzi oxidosqualene cyclase.
    Galli U; Oliaro-Bosso S; Taramino S; Venegoni S; Pastore E; Tron GC; Balliano G; Viola F; Sorba G
    Bioorg Med Chem Lett; 2007 Jan; 17(1):220-4. PubMed ID: 17027267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical Synthesis of α-Amyrin, β-Amyrin, and Lupeol: The Potential Natural Inhibitors of Human Oxidosqualene Cyclase.
    Chen D; Xu F; Zhang P; Deng J; Sun H; Wen X; Liu J
    Arch Pharm (Weinheim); 2017 Dec; 350(12):. PubMed ID: 29027714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase.
    Stach D; Zheng YF; Perez AL; Oehlschlager AC; Abe I; Prestwich GD; Hartman PG
    J Med Chem; 1997 Jan; 40(2):201-9. PubMed ID: 9003518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 4-piperidinopyridine inhibitors of oxidosqualene cyclase-lanosterol synthase derived by consideration of inhibitor pK(a).
    Brown GR; Foubister AJ; Johnson MC; Newcombe NJ; Waterson D; Wells SL
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2213-6. PubMed ID: 11514173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 2,3-oxidosqualene cyclases.
    Taton M; Benveniste P; Rahier A; Johnson WS; Liu HT; Sudhakar AR
    Biochemistry; 1992 Sep; 31(34):7892-8. PubMed ID: 1510977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 29-Methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase.
    Ceruti M; Rocco F; Viola F; Balliano G; Milla P; Arpicco S; Cattel L
    J Med Chem; 1998 Feb; 41(4):540-54. PubMed ID: 9484504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 2,3-oxidosqualene: beta-amyrin-cyclase, S-adenosyl-L-methionine: cycloartenol C-24-methyltransferase and cycloeucalenol: obtusifoliol isomerase by rationally designed molecules containing a tertiary amine function.
    Rahier A; Bouvier P; Cattel L; Narula A; Benveniste P
    Biochem Soc Trans; 1983 Oct; 11(5):537-43. PubMed ID: 6642064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cholesterol biosynthesis in 3T3 fibroblasts by 2-aza-2,3-dihydrosqualene, a rationally designed 2,3-oxidosqualene cyclase inhibitor.
    Gerst N; Schuber F; Viola F; Cattel L
    Biochem Pharmacol; 1986 Dec; 35(23):4243-50. PubMed ID: 3790151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.